Citation Impact

Citing Papers

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Perioperative Antibiotics in Thoracic Surgery
2011
Analysis and Characterization of Antiviral Drug–Resistant Cytomegalovirus Isolates from Solid Organ Transplant Recipients
2002
Pediatric lung transplantation for pulmonary hypertension and congenital heart disease
1992
Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation
2004
Bronchiolitis Obliterans Syndrome
2005
Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3- vs 12-Month Valganciclovir Therapy
2009
Obliterative bronchiolitis after lung and heart-lung transplantation
1995
Microemulsion-based media as novel drug delivery systems
2000 Standout
OPTIMIZATION OF THE IMMUNOSUPPRESSIVE PROTOCOL AFTER LUNG TRANSPLANTATION1
1999
Bronchiolitis Obliterans After Lung Transplantation
1998
Hallmarks of aging: An expanding universe
2023 Standout
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
2016
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
2011
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Cytomegalovirus and Lung Transplantation
2004
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
EFFICACY AND COST EFFECTIVENESS OF ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER LUNG TRANSPLANTATION1,2
1999
LUNG TRANSPLANTATION FOR PRIMARY PULMONARY HYPERTENSION
2001
Spirometry values in stable lung transplant recipients.
1997
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Lung and heart-lung transplantation in children
1997
Strategies to antagonise the cyclosporine A-induced proliferation of human pulmonary artery smooth muscle cells: anti-endothelin-1 antibodies, verapamil, and octreotide
2000
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2006
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2005
COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE (NEORAL) AND SDZ RAD IN NON-HUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMACOKINETIC-BASED TRIALS TO IMPROVE EFFICACY AND TOLERABILITY 1
2000
Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage
2016
HYPOGAMMAGLOBULINEMIA IN LUNG TRANSPLANT RECIPIENTS
2001
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Bronchiolitis Obliterans Syndrome: Alloimmune-Dependent and -Independent Injury with Aberrant Tissue Remodeling
2008
Nocardiosis at the Turn of the Century
2009 Standout
Ganciclovir
2001
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Acute respiratory distress syndrome
2019 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Idiopathic pulmonary fibrosis
2017 Standout
Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence
2016
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
2005
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Hallmarks of Cellular Senescence
2018 Standout
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Fibroageing: An ageing pathological feature driven by dysregulated extracellular matrix-cell mechanobiology
2021
Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols
2001
Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients
2002
Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes
2007 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
2020
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?
2017
Bronchiolitis Obliterans after Human Lung Transplantation
2002
Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease
2019
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis
2017
Infections in solid-organ transplant recipients
1997
Subtherapeutic ganciclovir (GCV) levels and GCV‐resistant cytomegalovirus in lung transplant recipients
2014
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Plasma membrane wounding and repair in pulmonary diseases
2017
Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts
2018
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Bronchiolitis Obliterans: Pathogenesis, Prevention, and Management
1998
Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens
2013
Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β‐catenin and AMPK pathways
2018 Standout
Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients
2005
Aspergillus fumigatusand Aspergillosis
1999 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
IPF lung fibroblasts have a senescent phenotype
2017
Bronchiolitis obliterans syndrome
1999
Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases
2016
Infection after lung transplantation.
1993
Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease
2015
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013

Works of Steve Duncan being referenced

Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
1996
Acute rejection of lung allografts with various immunosuppressive protocols
1992
Emerging Bacterial, Fungal, and Viral Respiratory Infections in Transplantation
2010
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.
1994
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
2014
The "natural history" of the transplanted lung: rates of pulmonary functional change in long-term survivors of heart-lung transplantation.
1991
Rankless by CCL
2026